A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids ; volume:12 ; number:1 ; day:12 ; month:1 ; year:2021 ; pages:1-13 ; date:12.2021
Nature Communications ; 12, Heft 1 (12.1.2021), 1-13, 12.2021
- Creator
-
Park, Jong-Chan
Jang, So-Yeong
Lee, Dongjoon
Lee, Jeongha
Kang, Uiryong
Chang, Hongjun
Kim, Haeng Jun
Han, Sun-Ho
Seo, Jinsoo
Choi, Murim
Lee, Dong Young
Byun, Min Soo
Yi, Dahyun
Cho, Kwang-Hyun
Mook-Jung, Inhee
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-20440-5
- URN
-
urn:nbn:de:101:1-2021020717580538450460
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:05 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Jong-Chan
- Jang, So-Yeong
- Lee, Dongjoon
- Lee, Jeongha
- Kang, Uiryong
- Chang, Hongjun
- Kim, Haeng Jun
- Han, Sun-Ho
- Seo, Jinsoo
- Choi, Murim
- Lee, Dong Young
- Byun, Min Soo
- Yi, Dahyun
- Cho, Kwang-Hyun
- Mook-Jung, Inhee
- SpringerLink (Online service)
Other Objects (12)
Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research
Exploring the role of RALYL in Alzheimer’s disease reserve by network-based approaches
A network-based, multi-omics integration framework for Alzheimer's disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
Alzheimer’s Disease
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease
Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
Alzheimer
Alzheimer
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer
Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research
Exploring the role of RALYL in Alzheimer’s disease reserve by network-based approaches
A network-based, multi-omics integration framework for Alzheimer's disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
Alzheimer’s Disease
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease
Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
Alzheimer
Alzheimer
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer
Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research
Exploring the role of RALYL in Alzheimer’s disease reserve by network-based approaches
A network-based, multi-omics integration framework for Alzheimer's disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
Alzheimer’s Disease
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease
Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
Alzheimer
Alzheimer